<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>Premenstrual Syndrome Clinical Trials Updates During the Last 45 Days</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/results/term=Premenstrual+Syndrome</link><description>Clinical trials database search returned 
 results for the query Premenstrual Syndrome AND ( "12/31/2011" : MAX ) [LAST-RELEASE-DATE].</description><pubDate>Tue, 14 Feb 2012 07:39:43 GMT</pubDate><atom:link href="http://www.clinicaltrialsfeeds.org/clinical-trials/rss/term=Premenstrual+Syndrome" rel="self" type="application/rss+xml" /><item><title>Regulatory Post Marketing Surveillance Study on YAZ</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00998257</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT00998257</guid><description>Status: Recruiting, 
Condition Summary: Contraception; Premenstrual Syndrome; Acne</description><pubDate>Wed, 18 Jan 2012 05:00:00 GMT</pubDate></item><item><title>A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumors</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01296555</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01296555</guid><description>Status: Recruiting, 
Condition Summary: Solid Cancers</description><pubDate>Thu, 19 Jan 2012 05:00:00 GMT</pubDate></item><item><title>Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, Observational Study</title><link>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525563</link><guid>http://www.clinicaltrialsfeeds.org/clinical-trials/show/NCT01525563</guid><description>Status: Not yet recruiting, 
Condition Summary: Irregular Menstrual Cycle</description><pubDate>Thu, 02 Feb 2012 05:00:00 GMT</pubDate></item></channel></rss>

